IL6 was identified originally as a B-cell differentiation factor, but was later found to affect cell growth, activation, and differentiation of multiple immune cells such as B and T lymphocytes, monocytes, dendritic cells, and tumor-infiltrating lymphocytes [13, 16–21]. Here, IL6 is linked to neoplasm.